Clinical Trials Browser

Interventional × Endometrial Serous Adenocarcinoma × Clear all

NCT04494113 2026-03-18

Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy

Phase EARLY_PHASE1 Active not recruiting

Endometrial Serous Adenocarcinoma

NCT02112552 2023-08-29

Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer

Phase 2 Terminated

4 enrolled 6 charts

Endometrial Serous Adenocarcinoma